Latest in Intellectual Property Appellate Board Archives - Access International Patent

India rejects patent on Pfizer’s arthritis drug

India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country. Pfizer sought a patent that covers an important chemical formulation of the active compound…

Read More

More Articles